Zobrazeno 1 - 10
of 16
pro vyhledávání: '"John Zaknun"'
Autor:
Sudipta Chakraborty, Nishikant Damle, Tapas Das, Praveen Kumar, John Zaknun, Meera Venkatesh, Chandrasekhar Bal, Geetanjali Arora, Sharmila Banerjee, M. R. A. Pillai
Publikováno v:
Current Radiopharmaceuticals. 9:71-84
177Lu-EDTMP has been proposed as a potent bone pain palliation agent owing to theoretical advantage of reduced bone marrow suppression resulting from the low β(-) energy and a suitably long half-life facilitating its wider distribution with less los
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a36eb969b816824a7da7d0d4e9dcb16b
https://doi.org/10.2174/1874471008666150313105000
https://doi.org/10.2174/1874471008666150313105000
Autor:
Sonya Sergieva, Sanjay Gambhir, John Zaknun, Irena Kostadinova, Vincent Peter Magboo, Francesco Giammarile, Thomas N.B. Pascual, Paulo Almeida, Dražen Huić, Heitor Naoki Sado, Ellmann A, Rossana Pruzzo, Renato A. Valdés-Olmos, Gabriela Oh Young, Alvaro Edmundo Calderon, R. V. Ramanathapuram Parameswaran, Mariza Vorster, Chandrasekhar Bal, Amelia Jimenez-Heffernan, Jonas Santiago
Publikováno v:
Journal of Nuclear Medicine. 56:1338-1344
We aimed to assess the additional value of SPECT/CT over planar lymphoscintigraphy (PI) in sentinel node (SN) detection in malignancies with different lymphatic drainage such as breast cancer, melanoma, and pelvic tumors.From 2010 to 2013, 1,508 pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c40219160000c6c09df1db71a870b0a6
https://doi.org/10.2967/jnumed.114.153643
https://doi.org/10.2967/jnumed.114.153643
Autor:
Yuankai Wang, Zhifu Luo, Xueqin Xiang, Guangming Zhang, Congjin Liu, Hongyu Li, Dayu Kuai, Xingdang Liu, James Robert Brašić, John Zaknun
Publikováno v:
Nuclear Medicine Communications. 33:90-96
ObjectivesLutetium-177-labeled ethylenediamine-N,N,N′,N′-tetrakis (methylene phosphonic acid) (177Lu-EDTMP), a beta-emitting bone-seeking therapeutic radiopharmaceutical being assessed as an agent for palliation of bone pain, can emit suitable ga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5befeb17402c480fa80f96a3e7228c7b
https://doi.org/10.1097/mnm.0b013e32834d3c13
https://doi.org/10.1097/mnm.0b013e32834d3c13
Autor:
Ravi Kashyap, Yaroslav Pynda, Maurizio Dondi, Fernando Mut Bastos, Thomas N.B. Pascual, Diana Paez, John Zaknun
Publikováno v:
Journal of Nuclear Medicine. 52:16S-23S
This article describes trends in nuclear medicine in the developing world as noted by nuclear medicine professionals at the International Atomic Energy Agency (IAEA). The trends identified are based on data gathered from several sources, including in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::014f5f44947ad92f87714686455c1225
https://doi.org/10.2967/jnumed.111.089193
https://doi.org/10.2967/jnumed.111.089193
Publikováno v:
Seminars in Nuclear Medicine. 41:73-80
Under the auspices of the International Atomic Energy Agency, a new-generation, platform-independent, and x86-compatible software package was developed for the analysis of scintigraphic renal dynamic imaging studies. It provides nuclear medicine prof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e43825d53e6e3e21bf4ace813b41230
https://doi.org/10.1053/j.semnuclmed.2010.09.002
https://doi.org/10.1053/j.semnuclmed.2010.09.002
Autor:
András Polyák, John Zaknun, Győző Jánoki, Lajos Balogh, Réka Király, M. R. A. Pillai, Dariusz Pawlak, Domokos Máthé, Teréz Márián
Publikováno v:
Nuclear Medicine and Biology. 37:215-226
Introduction Radionuclide therapy (RNT) is an effective method for bone pain palliation in patients suffering from bone metastasis. Due to the long half-life, easy production and relatively low β− energy, 177 Lu [ T 1/2 =6.73 days, E βmax =497 ke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19a4698b9562285a7c1ac31dd48c0f82
https://doi.org/10.1016/j.nucmedbio.2009.09.004
https://doi.org/10.1016/j.nucmedbio.2009.09.004
Autor:
Chaichon Locharernkul, Alex Maes, Wim Van Paesschen, John Zaknun, Chandrasekhar Bal, Maurizio Dondi, Silvina Carpintiero, Supatporn Tepmongkol, Silvia Vasquez, Patrick Dupont
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 36:823-830
To investigate dynamic ictal perfusion changes during temporal lobe epilepsy (TLE).We investigated 37 patients with TLE by ictal and interictal SPECT. All ictal injections were performed within 60 s of seizure onset. Statistical parametric mapping wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a4ca856d3cb2566ce9bf0a9d22d564b
https://doi.org/10.1007/s00259-008-1040-6
https://doi.org/10.1007/s00259-008-1040-6
Publikováno v:
Nuclear Medicine Communications. 29:260-269
BACKGROUND Quantifying hemispheric cerebral blood flow (CBF) may improve diagnostic accuracy when combined with perfusion SPECT. AIM To explore the impact of measuring mean CBF on the differential diagnosis of dementia under clinical conditions. METH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::188fcbf3e45d2cd7e3216eb77d0886bf
https://doi.org/10.1097/mnm.0b013e3282f38f8f
https://doi.org/10.1097/mnm.0b013e3282f38f8f
Autor:
Inas Al-Attar, Helmut Wachter, John Zaknun, Janet Kornegay, Pamela Chatis, Kenneth McIntosh, Daniela Zaknun, Dietmar Fuchs, Sandra K. Burchett, John Orav
Publikováno v:
The Journal of Pediatrics. 130:898-905
Objective: We investigated the relationship between cell-free viral load, neopterin, age-adjusted CD4 + cell concentration, and clinical events in 49 children with vertically acquired human immunodeficiency virus type 1 infection. Study design: Viral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d69938ccc89782d6f666c0d2e2aea928
https://doi.org/10.1016/s0022-3476(97)70275-0
https://doi.org/10.1016/s0022-3476(97)70275-0
Autor:
Richard P. Baum, John Zaknun, Martin Zeitz, Harshad R. Kulkarni, Patricia Grabowski, Dieter Hörsch, Franziska Briest
Publikováno v:
Drugs of today (Barcelona, Spain : 1998). 48(11)
The U.S. Food and Drug Administration (FDA) approved vandetanib in April 2011 for the treatment of unresectable, locally advanced or metastatic medullary thyroid cancer (MTC). In Europe it was approved in March 2012, but only for the treatment of agg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4eee8c0baf6c86e195145653107e0f9
https://pubmed.ncbi.nlm.nih.gov/23170308
https://pubmed.ncbi.nlm.nih.gov/23170308